Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

In this study we have investigated the effects of interleukin 10 (IL- 10) on human peripheral blood eosinophils stimulated with granulocyte/macrophage colony stimulating factor (GM-CSF) and lipopolysaccharide (LPS). We show that LPS was able to enhance eosinophil survival in a dose-dependent manner, as well as release of the cytokines GM-CSF, tumor necrosis factor alpha, and IL-8. LPS- induced eosinophil survival was largely inhibited by an anti-GM-CSF neutralizing antibody and completely blocked by polymyxin B, suggesting GM-CSF involvement in the survival enhancing mechanism and LPS specificity, respectively. IL-10 significantly inhibited survival of, and cytokine production from, eosinophils induced by LPS, but did not inhibit the survival induced by GM-CSF. These observations suggest a novel activation mechanism of eosinophils and, also, that IL-10 may participate in the regulation of diseases characterized by eosinophil infiltration.

[1]  G. Constantin,et al.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide , 1993, The Journal of experimental medicine.

[2]  M. Jordana,et al.  Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. , 1993, The American journal of pathology.

[3]  M. Jordana,et al.  Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. , 1993, American journal of respiratory cell and molecular biology.

[4]  D. Wong,et al.  Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. , 1993, The Journal of clinical investigation.

[5]  P. Weller,et al.  Mechanisms of eosinophil recruitment. , 1993, American journal of respiratory cell and molecular biology.

[6]  R. Braun,et al.  Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophore , 1993, European journal of immunology.

[7]  G. Firestein,et al.  Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. , 1992, The Journal of clinical investigation.

[8]  J. Abrams,et al.  Human eosinophils synthesize and secrete interleukin-6, in vitro. , 1992, Blood.

[9]  C. Harley,et al.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.

[10]  L. Lin,et al.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. , 1992, Journal of immunology.

[11]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[12]  M. Jordana,et al.  Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. , 1991, American journal of respiratory cell and molecular biology.

[13]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[14]  A. Wardlaw,et al.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils , 1991, The Journal of experimental medicine.

[15]  H. Kita,et al.  Materials and Methods Brief Definitive Report Granulocyte/macrophage Colony-stimulating Factor and Interleukin 3 Release from Human Peripheral Blood Eosinophils and Neutrophils , 2022 .

[16]  R. Schleimer,et al.  Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. , 1991, Journal of immunology.

[17]  M. Jordana,et al.  Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. , 1991, American journal of respiratory cell and molecular biology.

[18]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[19]  J. Cavaillon,et al.  Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. , 1990, Cytokine.

[20]  M. Jordana,et al.  Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. , 1989, American journal of respiratory cell and molecular biology.

[21]  C. Sanderson.  Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature , 1989 .

[22]  S. Wright,et al.  CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide , 1989, The Journal of experimental medicine.

[23]  A. Sheffer,et al.  Synthesis and release of leukotriene C4 by human eosinophils. , 1987, Journal of immunology.

[24]  C. Begley,et al.  Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. , 1986, Blood.

[25]  G. Gleich,et al.  The eosinophilic leukocyte: structure and function. , 1986, Advances in immunology.

[26]  Christopher J. F. Spry,et al.  Eosinophils in Disease , 1984 .

[27]  M. Vaara,et al.  Characterization of the lipopolysaccharide from the polymyxin‐resistant pmrA mutants of Salmonella typhimurium , 1981, FEBS letters.

[28]  D. Loegering,et al.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. , 1980, Laboratory investigation; a journal of technical methods and pathology.